サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1134177

人工角膜・角膜インプラントの世界市場：タイプ別、移植タイプ別、適応疾患別、エンドユーザー別の動向分析、競合の市場シェア、予測（2018年～2028年）

Global Artificial Cornea and Corneal Implant Market, By Type, By Transplant Type, By Disease Indication, By End-User Trend Analysis, Competitive Market Share & Forecast, 2018-2028
出版日: | 発行: Blueweave Consulting | ページ情報: 英文 142 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
人工角膜・角膜インプラントの世界市場：タイプ別、移植タイプ別、適応疾患別、エンドユーザー別の動向分析、競合の市場シェア、予測（2018年～2028年）
出版日: 2022年09月02日
発行: Blueweave Consulting
ページ情報: 英文 142 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の人工角膜・角膜インプラントの市場規模は、2021年の3億9,750万米ドルから2028年末までに約8億6,370万米ドルに達し、CAGRで12%の成長が予測されています。高齢化、眼病の流行、視覚障害を減らすための政府の取り組みなどが、市場を牽引する主な要因となっています。

当レポートでは、人工角膜・角膜インプラント市場について調査分析し、市場規模と予測、セグメント分析、地域分析、企業プロファイルなどを提供しています。

目次

第1章 調査の枠組み

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の人工角膜・角膜インプラント市場の考察

  • 業界バリューチェーン分析
  • DROC分析
    • 成長促進要因
    • 抑制要因
    • 機会
    • 課題
  • 技術の進歩/最近の発展
  • 規制の枠組み
  • ポーターのファイブフォース分析

第5章 世界の人工角膜・角膜インプラント市場の概要

  • 市場規模と予測（金額）（2018年～2028年）
  • 市場シェアと予測
    • タイプ別
      • ヒト角膜
      • 人工角膜
    • 移植タイプ別
      • 全層角膜移植
      • 角膜内皮移植
    • 適応疾患別
      • フックスジストロフィー
      • 真菌性角膜炎
      • 円錐角膜
      • その他
    • エンドユーザー別
      • 病院
      • 専門診療所
      • 外来手術センター
      • その他
    • 地域別
      • 北米
      • 欧州
      • アジア太平洋
      • ラテンアメリカ
      • 中東・アフリカ

第6章 北米の人工角膜・角膜インプラント市場

  • 市場規模と予測（金額）（2018年～2028年）
  • 市場シェアと予測
    • タイプ別
    • 移植タイプ別
    • 適応疾患別
    • エンドユーザー別
    • 国別
      • 米国
      • カナダ

第7章 欧州の人工角膜・角膜インプラント市場

  • 市場規模と予測（金額）（2018年～2028年）
  • 市場シェアと予測
    • タイプ別
    • 移植タイプ別
    • 適応疾患別
    • エンドユーザー別
    • 国別
      • ドイツ
      • 英国
      • イタリア
      • フランス
      • スペイン
      • その他の欧州

第8章 アジア太平洋の人工角膜・角膜インプラント市場

  • 市場規模と予測（金額）（2018年～2028年）
  • 市場シェアと予測
    • タイプ別
    • 移植タイプ別
    • 適応疾患別
    • エンドユーザー別
    • 国別
      • 中国
      • インド
      • 日本
      • 韓国
      • その他のアジア太平洋

第9章 ラテンアメリカの人工角膜・角膜インプラント市場

  • 市場規模と予測（金額）（2018年～2028年）
  • 市場シェアと予測
    • タイプ別
    • 移植タイプ別
    • 適応疾患別
    • エンドユーザー別
    • 国別
      • ブラジル
      • メキシコ
      • その他のラテンアメリカ

第10章 中東・アフリカの人工角膜・角膜インプラント市場

  • 市場規模と予測（金額）（2018年～2028年）
  • 市場シェアと予測
    • タイプ別
    • 移植タイプ別
    • 適応疾患別
    • エンドユーザー別
    • 国別
      • サウジアラビア
      • アラブ首長国連邦
      • 南アフリカ
      • その他の中東・アフリカ

第11章 競合情勢

  • 主要企業とその提供のリスト
  • 市場シェア分析（2021年）
  • 競合ベンチマーキング：経営パラメーター別
  • 主な戦略的発展（合併、買収、パートナーシップなど）

第12章 世界の人工角膜・角膜インプラント市場に対するCOVID-19の影響

第13章 企業プロファイル（企業の概要、財務マトリックス、競合情勢、主な人材、主な競合企業、連絡先、戦略的見通し）

  • AJL Ophthalmic
  • CorneaGen Inc
  • Addition Technology Inc
  • LinkoCare Life Science AB
  • Presbia Plc
  • Mediphacos
  • Aurolab
  • Cornea Biosciences
  • Dioptex GmbH
  • EyeYon Medical
  • Massachusetts Eye and Ear
  • Florida Lions Eye Bank
  • Other Prominent Players

第14章 主な戦略的推奨事項

図表

List of Figures

  • Figure 1: Global Artificial Cornea and Corneal Implant Market Segmentation
  • Figure 2: Global Artificial Cornea and Corneal Implant Market Industry Value Chain Analysis
  • Figure 3: Global Artificial Cornea and Corneal Implant Market Size, By Value (USD Million), 2018-2028
  • Figure 4: Global Artificial Cornea and Corneal Implant Market Share (%), By Type, By Value, 2018-2028
  • Figure 5: Global Artificial Cornea and Corneal Implant Market Share (%), By Transplant Type, By Value, 2018-2028
  • Figure 6: Global Artificial Cornea and Corneal Implant Market Share (%), By Disease Indication, By Value, 2018-2028
  • Figure 7: Global Artificial Cornea and Corneal Implant Market Share (%), By End-User, By Value, 2018-2028
  • Figure 8: Global Artificial Cornea and Corneal Implant Market Share (%), By Region, By Value, 2018-2028
  • Figure 9: North America Artificial Cornea and Corneal Implant Market Size, By Value (USD Million), 2018-2028
  • Figure 10: North America Artificial Cornea and Corneal Implant Market Share (%), By Type, By Value, 2018-2028
  • Figure 11: North America Artificial Cornea and Corneal Implant Market Share (%), By Transplant Type, By Value, 2018-2028
  • Figure 12: North America Artificial Cornea and Corneal Implant Market Share (%), By Disease Indication, By Value, 2018-2028
  • Figure 13: North America Artificial Cornea and Corneal Implant Market Share (%), By End-User, By Value, 2018-2028
  • Figure 14: North America Artificial Cornea and Corneal Implant Market Share (%), By Country, By Value, 2018-2028
  • Figure 15: Europe Artificial Cornea and Corneal Implant Market Size, By Value (USD Million), 2018-2028
  • Figure 16: Europe Artificial Cornea and Corneal Implant Market Share (%), By Type, By Value, 2018-2028
  • Figure 17: Europe Artificial Cornea and Corneal Implant Market Share (%), By Transplant Type, By Value, 2018-2028
  • Figure 18: Europe Artificial Cornea and Corneal Implant Market Share (%), By Disease Indication, By Value, 2018-2028
  • Figure 19: Europe Artificial Cornea and Corneal Implant Market Share (%), By End-User, By Value, 2018-2028
  • Figure 20: Europe Artificial Cornea and Corneal Implant Market Share (%), By Country, By Value, 2018-2028
  • Figure 21: The Asia-Pacific Artificial Cornea and Corneal Implant Market Size, By Value (USD Million), 2018-2028
  • Figure 22: The Asia-Pacific Artificial Cornea and Corneal Implant Market Share (%), By Type, By Value, 2018-2028
  • Figure 23: The Asia-Pacific Artificial Cornea and Corneal Implant Market Share (%), By Transplant Type, By Value, 2018-2028
  • Figure 24: The Asia-Pacific Artificial Cornea and Corneal Implant Market Share (%), By Disease Indication, By Value, 2018-2028
  • Figure 25: The Asia-Pacific Artificial Cornea and Corneal Implant Market Share (%), By End-User, By Value, 2018-2028
  • Figure 26: The Asia-Pacific Artificial Cornea and Corneal Implant Market Share (%), By Country, By Value, 2018-2028
  • Figure 27: Latin America Artificial Cornea and Corneal Implant Market Size, By Value (USD Million), 2018-2028
  • Figure 28: Latin America Artificial Cornea and Corneal Implant Market Share (%), By Type, By Value, 2018-2028
  • Figure 29: Latin America Artificial Cornea and Corneal Implant Market Share (%), By Transplant Type, By Value, 2018-2028
  • Figure 30: Latin America Artificial Cornea and Corneal Implant Market Share (%), By Disease Indication, By Value, 2018-2028
  • Figure 31: Latin America Artificial Cornea and Corneal Implant Market Share (%), By End-User, By Value, 2018-2028
  • Figure 32: Latin America Artificial Cornea and Corneal Implant Market Share (%), By Country, By Value, 2018-2028
  • Figure 33: The Middle East & Africa Artificial Cornea and Corneal Implant Market Size, By Value (USD Million), 2018-2028
  • Figure 34: The Middle East & Africa Artificial Cornea and Corneal Implant Market Share (%), By Type, By Value, 2018-2028
  • Figure 35: The Middle East & Africa Artificial Cornea and Corneal Implant Market Share (%), By Transplant Type, By Value, 2018-2028
  • Figure 36: The Middle East & Africa Artificial Cornea and Corneal Implant Market Share (%), By Disease Indication, By Value, 2018-2028
  • Figure 37: The Middle East & Africa Artificial Cornea and Corneal Implant Market Share (%), By End-User, By Value, 2018-2028
  • Figure 38: The Middle East & Africa Artificial Cornea and Corneal Implant Market Share (%), By Country, By Value, 2018-2028
  • Figure 39: Global Artificial Cornea and Corneal Implant Market Share Analysis, 2021

 

List of Tables

  • Table 1: Global Artificial Cornea and Corneal Implant Market Size, By Type, By Value (USD Million), 2018-2028
  • Table 2: Global Artificial Cornea and Corneal Implant Market Size, By Transplant Type, By Value (USD Million), 2018-2028
  • Table 3: Global Artificial Cornea and Corneal Implant Market Size, By Disease Indication, By Value (USD Million), 2018-2028
  • Table 4: Global Artificial Cornea and Corneal Implant Market Size, By End-User, By Value (USD Million), 2018-2028
  • Table 5: Global Artificial Cornea and Corneal Implant Market Size. By Region, By Value (USD Million), 2018-2028
  • Table 6: North America Artificial Cornea and Corneal Implant Market Size, By Type, By Value (USD Million), 2018-2028
  • Table 7: North America Artificial Cornea and Corneal Implant Market Size, By Transplant Type, By Value (USD Million), 2018-2028
  • Table 8: North America Artificial Cornea and Corneal Implant Market Size, By Disease Indication, By Value (USD Million), 2018-2028
  • Table 9: North America Artificial Cornea and Corneal Implant Market Size, By End-User, By Value (USD Million), 2018-2028
  • Table 10: North America Artificial Cornea and Corneal Implant Market Size (USD Million), By Country, By Value 2018-2028
  • Table 11: Europe Artificial Cornea and Corneal Implant Market Size, By Type, By Value (USD Million), By Value 2018-2028
  • Table 12: Europe Artificial Cornea and Corneal Implant Market Size, By Transplant Type, By Value (USD Million), By Value 2018-2028
  • Table 13: Europe Artificial Cornea and Corneal Implant Market Size, By Disease Indication, By Value (USD Million), By Value 2018-2028
  • Table 14: Europe Artificial Cornea and Corneal Implant Market Size, By End-User, By Value (USD Million), By Value 2018-2028
  • Table 15: 40 Europe Artificial Cornea and Corneal Implant Market Size (USD Million), By Country, By Value 2018-2028
  • Table 16: The Asia-Pacific Artificial Cornea and Corneal Implant Market Size, By Type, By Value (USD Million), By Value 2018-2028
  • Table 17: The Asia-Pacific Artificial Cornea and Corneal Implant Market Size (USD Million), By Type, By Value 2018-2028
  • Table 18: The Asia-Pacific Artificial Cornea and Corneal Implant Market Size (USD Million), By Transplant Type, By Value 2018-2028
  • Table 19: The Asia-Pacific Artificial Cornea and Corneal Implant Market Size (USD Million), By Disease Indication, By Value 2018-2028
  • Table 20: The Asia-Pacific Artificial Cornea and Corneal Implant Market Size (USD Million), By End-User, By Value 2018-2028
  • Table 21: The Asia-Pacific Artificial Cornea and Corneal Implant Market Size (USD Million), By Country, By Value 2018-2028
  • Table 22: Latin America Artificial Cornea and Corneal Implant Market Size, By Type, By Value (USD Million), By Value 2018-2028
  • Table 23: Latin America Artificial Cornea and Corneal Implant Market Size, By Transplant Type, By Value (USD Million), 2018-2028
  • Table 24: Latin America Artificial Cornea and Corneal Implant Market Size, By Disease Indication, By Value (USD Million), 2018-2028
  • Table 25: Latin America Artificial Cornea and Corneal Implant Market Size, By End-User, By Value (USD Million), 2018-2028
  • Table 26: Latin America Artificial Cornea and Corneal Implant Market Size (USD Million), By Country, By Value 2018-2028
  • Table 27: The Middle East & Africa Artificial Cornea and Corneal Implant Market Size, By Type, By Value (USD Million), 2018-2028
  • Table 28: The Middle East & Africa Artificial Cornea and Corneal Implant Market Size, By Transplant Type, By Value (USD Million), 2018-2028
  • Table 29: The Middle East & Africa Artificial Cornea and Corneal Implant Market Size, By Disease Indication, By Value (USD Million), 2018-2028
  • Table 30: The Middle East & Africa Artificial Cornea and Corneal Implant Market Size, By End-User, By Value (USD Million), 2018-2028
  • Table 31: The Middle East & Africa Artificial Cornea and Corneal Implant Market Size (USD Million), By Country, By Value 2018-2028
  • Table 32: List of Key Players and Their Offerings
  • Table 33: Competitive Benchmarking, by Operating Parameters
  • Table 34 AJL Ophthalmic Company Overview
  • Table 35 AJL Ophthalmic Financial Overview
  • Table 36 CorneaGen Inc Company Overview
  • Table 37 CorneaGen Inc Financial Overview
  • Table 38 Addition Technology Inc Company Overview
  • Table 39 Addition Technology Inc Financial Overview
  • Table 40 LinkoCare Life Science AB Company Overview
  • Table 41 LinkoCare Life Science AB Financial Overview
  • Table 42 Presbia Plc Company Overview
  • Table 43 Presbia Plc Financial Overview
  • Table 44 Mediphacos Company Overview
  • Table 45 Mediphacos Financial Overview
  • Table 46 Aurolab Company Overview
  • Table 47 Aurolab Financial Overview
  • Table 48 Cornea Biosciences Company Overview
  • Table 49 Cornea Biosciences Financial Overview
  • Table 50 Dioptex GmbH Company Overview
  • Table 51 Dioptex GmbH Financial Overview
  • Table 52 EyeYon Medical Company Overview
  • Table 53 EyeYon Medical Financial Overview
  • Table 54 Massachusetts Eye and Ear Company Overview
  • Table 55 Massachusetts Eye and Ear Financial Overview
  • Table 56 Florida Lions Eye Bank Company Overview
  • Table 57 Florida Lions Eye Bank Financial Overview
目次
Product Code: BWC22331

Global Artificial Cornea and Corneal Implant Market to Grow at a CAGR of 12% until 2028

The aging population, increased incidence of eye diseases, government initiatives to lessen visual impairment, and the rising prevalence of eye diseases are the main factors driving the Global Artificial Cornea and Corneal Implant Market.

A recent study conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the Global Artificial Cornea and Corneal Implant Market was worth USD 397.5 million in the year 2021. The market is projected to grow at a CAGR of 12%, earning revenues of around USD 863.7 million by the end of 2028. The Global Artificial Cornea and Corneal Implant Market are booming because the willingness of the consumer to spend money on eye care is credited with driving the expansion in the artificial cornea implant market. Additionally, the main driver of the market's growth is the rise in ophthalmic illnesses such as keratoconus, Fuchs dystrophy, and viral keratitis. In addition, rising healthcare costs for eye treatment in emerging nations are fueling the expansion of the artificial cornea implant market globally. Additionally, the market can expand as a result of factors including the rise in surgical procedures and the demand for innovative treatment methods. The development of the global artificial cornea implant market, however, is threatened by the high cost of cornea implant surgeries. Additionally, complications from corneal procedures hinder the widespread use of corneal implants.

Eye Diseases Are Increasingly Common

The global population of persons suffering from serious eye problems is growing, and vision loss is becoming a major public health concern. The rising prevalence of chronic diseases such as diabetes and hypertension, as well as the aging population, have all contributed to an increase in the prevalence of eye diseases such as diabetic retinopathy and ocular hypertension (glaucoma). The number of blind or low-vision people is likewise predicted to climb dramatically. According to the Royal National Institute of Blind People (RNIB), over 2 million people in the United Kingdom suffered from sight loss in 2013, with that number expected to climb to 4.1 million by 2050. The globe now, there are 146 million cases of trachoma, of which 10 million have trichiasis and need surgery to prevent corneal blindness, and 4.9 million have trachomatous corneal scarring that has caused them to become completely blind. This results in offering lucrative opportunities for the Global Artificial Cornea and Corneal Implant Market during the forecast period (2022-2028).

Lack of Corneal Donors

There is an urgent need for corneal donors because around 10 million people worldwide require corneal transplants. Because of a significant lack of donor corneas, there is a more than six-month waiting list for corneal transplants among those with corneal blindness in densely populated countries like India. About 1 million Americans and 6.8 million persons in the country, respectively, suffer visual problems in both eyes as a result of corneal diseases. By the end of 2020, 10.6 million cases of unilateral corneal blindness were expected to occur in India. In 2019, there were about 120,000 cases of corneal blindness. Although the country needs roughly 250,000 corneas annually, only about 25,000 are donated. Given the significant burden of corneal blindness and the scarcity of corneal donors, manufacturers of corneal implants should have significant development potential.

Challenges: Insufficient Ophthalmologists

Ophthalmologists are still in great demand, although their numbers have not grown as quickly as the global population. This is especially clear in emerging nations. In India, for instance, there is one ophthalmologist for every 107,000 people, compared to one for every 15,800 in the US. While some locations (mostly urban centers) have ratios of 1:9,000, other others have ratios as low as 1:608,000. The average number of ophthalmologists per million inhabitants varies depending on the country's level of economic development, from nine per million on average in low-income nations to 79 per million on average in high-income nations. There were more than 100 ophthalmologists per million persons in just 18 countries (Source: World Bank).

Segmental Coverage

Global Artificial Cornea and Corneal Implant Market - By End-User

Based on end-user, the Global Artificial Cornea and Corneal Implant Market is segmented into Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others. During the projected period, the category for specialty clinics and ASCs is anticipated to have the greatest CAGR. The decline in in-patient surgeries and the rise in demand for minimally invasive procedures are both factors contributing to this segment's growth. Concerns about hospital-acquired infections and patient preferences for effective treatment are further fostering the expansion of this market.

Impact of COVID-19 on Global Artificial Cornea and Corneal Implant Market

Due to lockdowns and other restrictions put in place to stop the COVID-19 epidemic, there has been a considerable decrease in the number of patient visits to clinics in the first and second quarters of 2020. As a result, fewer elective eye procedures were performed each week in hospitals and clinics during that time. The number of elective procedures has decreased from 200 surgeries per week to just ten surgeries per week, according to the Ophthalmology Times story. Additionally, the frequency of patient appointments to examination centers has been canceled by 15% in nations like the US. The coronavirus disease (COVID-19) pandemic caused a large loss in patient volume for ophthalmology, according to the same publication. According to estimates, the number of patients seeking glaucoma treatment decreased by 88% and those seeking cataract surgery by 97%. Government programs assisted numerous practices during this time, including Paycheck Protection Program loans, which enabled the ophthalmology sector to successfully continue operations

Competitive Landscape

The leading market players in the Global Artificial Cornea and Corneal Implant Market are AJL Ophthalmic, CorneaGen Inc, Addition Technology Inc, LinkoCare Life Science AB, Presbia Plc, Mediphacos, Aurolab, Cornea Biosciences, Dioptex GmbH, EyeYon Medical, Massachusetts Eye and Ear, Florida Lions Eye Bank, and other prominent players.

The Global Artificial Cornea and Corneal Implant Market is highly fragmented with the presence of several manufacturing companies in the country. The market leaders retain their supremacy by spending on research and development, incorporating cutting-edge technology into their goods, and releasing upgraded items for customers. Various tactics, including strategic alliances, agreements, mergers, and partnerships, are used.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the Global Artificial Cornea and Corneal Implant Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Artificial Cornea and Corneal Implant Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Transplant Type Overview
  • 1.3. Market Segmentation

2. Research Methodology

  • 2.1. Qualitative Research
    • 2.1.1. Primary & Secondary Research
  • 2.2. Quantitative Research
  • 2.3. Market Breakdown & Data Triangulation
    • 2.3.1. Secondary Research
    • 2.3.2. Primary Research
  • 2.4. Breakdown of Primary Research Respondents
  • 2.5. Assumption & Limitation

3. Executive Summary

4. Global Artificial Cornea and Corneal Implant Market Insights

  • 4.1. Industry Value Chain Analysis
  • 4.2. DROC Analysis
    • 4.2.1. Growth Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
    • 4.2.4. Challenges
  • 4.3. Technological Advancement/Recent Development
  • 4.4. Regulatory Framework
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of New Entrants
    • 4.5.4. Threat of Substitutes
    • 4.5.5. Intensity of Rivalry

5. Global Artificial Cornea and Corneal Implant Market Overview

  • 5.1. Market Size & Forecast by Value, 2018-2028
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type
      • 5.2.1.1. Human Cornea
      • 5.2.1.2. Artificial Cornea
    • 5.2.2. By Transplant Type
      • 5.2.2.1. Penetrating Keratoplasty
      • 5.2.2.2. Endothelial Keratoplasty
    • 5.2.3. By Disease Indication
      • 5.2.3.1. Fuch's Dystrophy
      • 5.2.3.2. Fungal Keratitis
      • 5.2.3.3. Keratoconus
      • 5.2.3.4. Others
    • 5.2.4. By End-User
      • 5.2.4.1. Hospitals
      • 5.2.4.2. Specialty Clinics
      • 5.2.4.3. Ambulatory Surgical Centers
      • 5.2.4.4. Others
    • 5.2.5. By Region
      • 5.2.5.1. North America
      • 5.2.5.2. Europe
      • 5.2.5.3. The Asia Pacific
      • 5.2.5.4. Latin America
      • 5.2.5.5. The Middle East and Africa

6. North America Artificial Cornea and Corneal Implant Market

  • 6.1. Market Size & Forecast by Value, 2018-2028
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Transplant Type
    • 6.2.3. By Disease Indication
    • 6.2.4. By End-User
    • 6.2.5. By Country
      • 6.2.5.1. United Type
      • 6.2.5.2. Canada

7. Europe Artificial Cornea and Corneal Implant Market

  • 7.1. Market Size & Forecast by Value, 2018-2028
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Transplant Type
    • 7.2.3. By Disease Indication
    • 7.2.4. By End-User
    • 7.2.5. By Country
      • 7.2.5.1. Germany
      • 7.2.5.2. United Kingdom
      • 7.2.5.3. Italy
      • 7.2.5.4. France
      • 7.2.5.5. Spain
      • 7.2.5.6. Rest of Europe

8. The Asia Pacific Artificial Cornea and Corneal Implant Market

  • 8.1. Market Size & Forecast by Value, 2018-2028
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Transplant Type
    • 8.2.3. By Disease Indication
    • 8.2.4. By End-User
    • 8.2.5. By Country
      • 8.2.5.1. China
      • 8.2.5.2. India
      • 8.2.5.3. Japan
      • 8.2.5.4. South Korea
      • 8.2.5.5. Rest of Asia Pacific

9. Latin America Artificial Cornea and Corneal Implant Market

  • 9.1. Market Size & Forecast by Value, 2018-2028
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Transplant Type
    • 9.2.3. By Disease Indication
    • 9.2.4. By End-User
    • 9.2.5. By Country
      • 9.2.5.1. Brazil
      • 9.2.5.2. Mexico
      • 9.2.5.3. Rest of Latin America

10. The Middle East & Africa Artificial Cornea and Corneal Implant Market

  • 10.1. Market Size & Forecast by Value, 2018-2028
    • 10.1.1. By Value (USD Million)
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Transplant Type
    • 10.2.3. By Disease Indication
    • 10.2.4. By End-User
    • 10.2.5. By Country
      • 10.2.5.1. Saudi Arabia
      • 10.2.5.2. UAE
      • 10.2.5.3. South Africa
      • 10.2.5.4. Rest of the Middle East & Africa

11. Competitive Landscape

  • 11.1. List of Key Players and Their Offerings
  • 11.2. Market Share Analysis, 2021
  • 11.3. Competitive Benchmarking, By Operating Parameters
  • 11.4. Key Strategic Development (Mergers, Acquisitions, Partnerships, etc.)

12. Impact of Covid-19 on Global Artificial Cornea and Corneal Implant Market

13. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) **

  • 13.1. AJL Ophthalmic
  • 13.2. CorneaGen Inc
  • 13.3. Addition Technology Inc
  • 13.4. LinkoCare Life Science AB
  • 13.5. Presbia Plc
  • 13.6. Mediphacos
  • 13.7. Aurolab
  • 13.8. Cornea Biosciences
  • 13.9. Dioptex GmbH
  • 13.10. EyeYon Medical
  • 13.11. Massachusetts Eye and Ear
  • 13.12. Florida Lions Eye Bank
  • 13.13. Other Prominent Players

14. Key Strategic Recommendations

*Financial information in case of non-listed companies will be provided as per availability

**The segmentation and the companies are subjected to modifications based on the in-depth secondary for the final deliverable